EyePoint, Inc. (EYPT)
4.875
-0.44
(-8.36%)
USD |
NASDAQ |
Aug 24, 16:00
4.89
+0.02
(+0.31%)
After-Hours: 20:00
EyePoint Debt to Equity Ratio : 0.1344 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1344 |
| March 31, 2026 | 0.0968 |
| December 31, 2025 | 0.0745 |
| September 30, 2025 | 0.1162 |
| June 30, 2025 | 0.0887 |
| March 31, 2025 | 0.0807 |
| December 31, 2024 | 0.0687 |
| September 30, 2024 | 0.1061 |
| June 30, 2024 | 0.102 |
| March 31, 2024 | 0.0229 |
| December 31, 2023 | 0.0205 |
| September 30, 2023 | 0.1065 |
| June 30, 2023 | 0.1122 |
| March 31, 2023 | 0.5248 |
| December 31, 2022 | 0.4809 |
| September 30, 2022 | 0.3407 |
| June 30, 2022 | 0.2966 |
| March 31, 2022 | 0.2521 |
| December 31, 2021 | 0.2128 |
| September 30, 2021 | 0.4235 |
| June 30, 2021 | 0.3649 |
| March 31, 2021 | 0.3547 |
| December 31, 2020 | 2.215 |
| September 30, 2020 | 7.093 |
| June 30, 2020 | 12.77 |
| Date | Value |
|---|---|
| March 31, 2020 | 3.10 |
| December 31, 2019 | 6.075 |
| September 30, 2019 | 3.151 |
| June 30, 2019 | 1.767 |
| March 31, 2019 | 1.608 |
| December 31, 2018 | 0.4682 |
| September 30, 2018 | 0.3661 |
| June 30, 2018 | 1.481 |
| March 31, 2018 | 1.568 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Ocular Therapeutix, Inc. | 0.1526 |
| Eli Lilly & Co. | 1.621 |
| Elanco Animal Health, Inc. | 0.5947 |
| Amylyx Pharmaceuticals, Inc. | 0.022 |
| Nuvation Bio, Inc. | 1.640 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 228.19M |
| Total Liabilities (Quarterly) | 61.78M |
| Shareholders Equity (Quarterly) | 166.41M |
| Current Ratio | 4.502 |
| Net Debt Paydown Yield | 0.03% |